AUA2019 037IC Help Patients Decide On Prostate Cancer Screening And Treatment
AUAUniversity5 Heinä 2019

AUA2019 037IC Help Patients Decide On Prostate Cancer Screening And Treatment

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: https://auau.auanet.org/node/24579 Instructional Course Director(s) Danil Makarov, MD photo Danil Makarov, MD New York University School of Medicine Instructional Course Faculty(s) Michael Barry, MD Harvard Medical School Angela Fagerlin, MD Chair, Department of Population Health Sciences Shared Decision Making was recently accepted as the standard of care when counseling patients considering PSA screening by the US Preventative Services Taskforce. Shared Decision Making is also embedded into numerous recently published AUA guidelines (including the localized prostate cancer guideline). In spite of these clear recommendations, Shared Decision Making is not frequently used in clinical practice. We propose a course that would teach the essentials of Shared Decision Making (SDM) to practicing urologists who help patients decide about prostate cancer screening and treatment. The course will go over the latest research documenting the benefits and drawbacks of Shared Decision Making when counseling patients considering PSA screening as well as treatment approaches for incident localized prostate cancer. It will also teach the participants how to practice SDM with their patients and will engage them in group-based role play. At the end of the session, participants will understand how to apply SDM in their practice. Learning Objectives: Explain Shared Decision Making. Discuss the impact of shared decision making on patients and on patient-clinician communication. Describe at least one implementation strategy for using shared decision making in clinical practice. Explain Shared Decision Making techniques in a role playing exercise with other attendees. Apply the knowledge they have gained through role play into their routine practice counseling patients.

Jaksot(422)

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

29 Loka 201837min

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer is the second in the 4-part series. Topics will include "non muscle invasive disease" and "muscle invasive disease" as well as "clinical trial evidence" and ...

24 Loka 201854min

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

Speakers: Christopher M. Gonzalez, MD, MBA James M. Dupree, MD, MPH

22 Loka 201817min

Incorporating New IO Therapies - Managing Patient Side Effects

Incorporating New IO Therapies - Managing Patient Side Effects

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

19 Loka 201830min

Immuno - Oncoloy: A New Class Of Drugs

Immuno - Oncoloy: A New Class Of Drugs

Immuno-Oncology: A New Class of Drugs is the first in the 4-part series. Topics will include "Tumor Immunotherapy", "Immunotherapy Drug Availability and Mechanisms of Action", "Vaccines", "Monoclonal ...

10 Loka 201842min

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer: What's New is the third podcast in a 4-part series. Topics will include "Manipulating the Androgen Axis: Androgen Biosynthe...

8 Loka 201856min

Incorporating New IO Therapies - Biomarkers

Incorporating New IO Therapies - Biomarkers

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

4 Loka 201829min

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation are producing a serie...

28 Syys 201851min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
rss-narsisti
voi-hyvin-meditaatiot-2
aamukahvilla
rss-niinku-asia-on
rss-liian-kuuma-peruna
adhd-podi
psykologia
kesken
rss-vapaudu-voimaasi
rss-valo-minussa-2
dear-ladies
rss-koira-haudattuna
jari-sarasvuo-podcast
esa-saarinen-filosofia-ja-systeemiajattelu
leveli
rss-duodecim-lehti
rss-luonnollinen-synnytys-podcast
rss-ihana-elamani